Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.

Gómez CE, Perdiguero B, García-Arriaza J, Cepeda V, Sánchez-Sorzano CÓ, Mothe B, Jiménez JL, Muñoz-Fernández MÁ, Gatell JM, López Bernaldo de Quirós JC, Brander C, García F, Esteban M.

PLoS One. 2015 Nov 6;10(11):e0141456. doi: 10.1371/journal.pone.0141456. eCollection 2015.

2.

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M.

J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14. Epub 2014 Oct 29.

3.

Draft genome sequence and transcriptome analysis of the wine spoilage yeast Dekkera bruxellensis LAMAP2480 provides insights into genetic diversity, metabolism and survival.

Valdes J, Tapia P, Cepeda V, Varela J, Godoy L, Cubillos FA, Silva E, Martinez C, Ganga MA.

FEMS Microbiol Lett. 2014 Dec;361(2):104-6.

4.

Novel insights on the progression of intermediate viral forms in the morphogenesis of vaccinia virus.

Cepeda V, Esteban M.

Virus Res. 2014 Apr;183:23-9. doi: 10.1016/j.virusres.2014.01.016. Epub 2014 Jan 24.

PMID:
24468494
5.

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

García-Arriaza J, Cepeda V, Hallengärd D, Sorzano CÓ, Kümmerer BM, Liljeström P, Esteban M.

J Virol. 2014 Mar;88(6):3527-47. doi: 10.1128/JVI.03418-13. Epub 2014 Jan 8.

6.

Ssa miRNAs DB: Online repository of in silico predicted miRNAs in Salmo salar.

Reyes D, Cepeda V, González R, Vidal R.

Bioinformation. 2012;8(6):284-6. doi: 10.6026/97320630008284. Epub 2012 Mar 31.

7.

A role for the SNARE protein syntaxin 3 in human cytomegalovirus morphogenesis.

Cepeda V, Fraile-Ramos A.

Cell Microbiol. 2011 Jun;13(6):846-58. doi: 10.1111/j.1462-5822.2011.01583.x. Epub 2011 Mar 4.

PMID:
21371234
8.

Rab27a is required for human cytomegalovirus assembly.

Fraile-Ramos A, Cepeda V, Elstak E, van der Sluijs P.

PLoS One. 2010 Dec 8;5(12):e15318. doi: 10.1371/journal.pone.0015318.

9.

Human cytomegalovirus final envelopment on membranes containing both trans-Golgi network and endosomal markers.

Cepeda V, Esteban M, Fraile-Ramos A.

Cell Microbiol. 2010 Mar;12(3):386-404. doi: 10.1111/j.1462-5822.2009.01405.x. Epub 2009 Nov 2.

PMID:
19888988
10.

Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.

Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Soto M, Pérez JM.

Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):39-53. Review.

PMID:
18221025
11.

Biochemical mechanisms of cisplatin cytotoxicity.

Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Pérez JM.

Anticancer Agents Med Chem. 2007 Jan;7(1):3-18. Review.

PMID:
17266502
12.

Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin.

Nguewa PA, Fuertes MA, Cepeda V, Iborra S, Carrión J, Valladares B, Alonso C, Pérez JM.

Chem Biodivers. 2005 Oct;2(10):1387-400.

PMID:
17191940
13.

Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells.

Nguewa PA, Fuertes MA, Cepeda V, Alonso C, Quevedo C, Soto M, Pérez JM.

Med Chem. 2006 Jan;2(1):47-53.

PMID:
16787355
14.

Molecular mechanisms for the B-Z transition in the example of poly[d(G-C) x d(G-C)] polymers. A critical review.

Fuertes MA, Cepeda V, Alonso C, Pérez JM.

Chem Rev. 2006 Jun;106(6):2045-64. Review. No abstract available.

PMID:
16771442

Supplemental Content

Loading ...
Support Center